Zhitong Finance App News, Lianhuan Pharmaceutical (600513.SH) issued an announcement. The company recently received the “Drug Registration Certificate” for lactulose oral solution (200ml: 133.4g/15ml: 10g) approved and issued by the State Drug Administration. This medication is indicated for chronic or habitual constipation: regulates the physiological rhythm of the colon; hepatic encephalopathy: used to treat and prevent hepatic coma or pre-coma states.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.